Concordia Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CONCORDIA, and what generic and branded alternatives to CONCORDIA drugs are available?
CONCORDIA has fifteen approved drugs.
Drugs and US Patents for Concordia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concordia | DYRENIUM | triamterene | CAPSULE;ORAL | 013174-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Concordia | ZONEGRAN | zonisamide | CAPSULE;ORAL | 020789-002 | Aug 22, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Concordia | LANOXIN | digoxin | TABLET;ORAL | 020405-003 | Sep 30, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Concordia Pharms Inc | KAPVAY | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-004 | Sep 28, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Concordia | PARNATE | tranylcypromine sulfate | TABLET;ORAL | 012342-003 | Aug 16, 1985 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Concordia Pharms Inc | ORAPRED ODT | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 021959-002 | Jun 1, 2006 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Concordia
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Concordia Pharms Inc | KAPVAY | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-004 | Sep 28, 2010 | 5,869,100 | ⤷ Try a Trial |
Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-002 | May 25, 2010 | 5,869,100 | ⤷ Try a Trial |
Concordia | PANRETIN | alitretinoin | GEL;TOPICAL | 020886-001 | Feb 2, 1999 | 7,056,954 | ⤷ Try a Trial |
Concordia Pharms Inc | ORAPRED ODT | prednisolone sodium phosphate | TABLET, ORALLY DISINTEGRATING;ORAL | 021959-002 | Jun 1, 2006 | 6,024,981 | ⤷ Try a Trial |
Concordia | UROXATRAL | alfuzosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021287-001 | Jun 12, 2003 | 4,661,491*PED | ⤷ Try a Trial |
Concordia | ZONEGRAN | zonisamide | CAPSULE;ORAL | 020789-001 | Mar 27, 2000 | 6,342,515 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for CONCORDIA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 10 mg | ➤ Subscribe | 2007-06-12 |
➤ Subscribe | Extended-release Tablets | 0.1 mg and 0.2 mg | ➤ Subscribe | 2011-03-04 |
➤ Subscribe | Orally Disintegrating Tablets | 10 mg, 15 mg and 30 mg | ➤ Subscribe | 2010-07-22 |
➤ Subscribe | Extended-release Tablets | 0.1 mg and 0.2 mg | ➤ Subscribe | 2011-03-04 |
Similar Applicant Names
Here is a list of applicants with similar names.